Italia markets closed

BMY Sep 2024 47.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,8300+0,4800 (+35,56%)
Alla chiusura: 03:49PM EDT
Schermo intero
Chiusura precedente1,3500
Aperto1,7500
Denaro1,8100
Lettera1,8600
Prezzo d'esercizio47,00
Scadenza2024-09-20
Min-Max giorno1,7400 - 1,8300
Contratto - Min-MaxN/D
Volume53
Open Interest307
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri